Home » Topics » Regulatory

Regulatory
RSS

Shire's once-daily Adderall XR launched in U.S. for treatment of ADHD

Oct. 30, 2001

First regulatory approval obtained for Viread

Oct. 30, 2001

Successful completion of oxymorphone pain management clinical trial

Oct. 30, 2001

Novartis receives approvable letter for Diovan as treatment for heart failure

Oct. 26, 2001

Amgen submits supplemental application with EMEA for anemia product

Oct. 26, 2001

Nonopioid analgesic effects reported for nitecapone and other COMT inhibitors

Oct. 25, 2001

Tipifarnib-based antitumor combinations extensively patented by Janssen

Oct. 24, 2001

Zometa will receive priority review for treatment of bone metastases

Oct. 24, 2001

Clinical trials of Remicade for congestive heart failure put on hold

Oct. 24, 2001

FDA grants expedited approval for Protonix I.V. in Zollinger-Ellison syndrome Rx

Oct. 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...